Active Drug Safety Monitoring and Management/Pharmacovigilance
Sample Serious Adverse Event forms:
WHO Guidelines and Recommendations
These materials can be used as part of a training workshop for clinicians who will treat MDR-TB patients with bedaquiline or delamanid. The modules can be used individually or in combination with additional materials based on each unique setting.